NeuroPace
NeuroPace, a California-based manufacturer, designs and markets implantable devices for treating neurological disorders.
Founded
1997NeuroPace, a California-based manufacturer, designs and markets implantable devices for treating neurological disorders.
NeuroPace, founded in Mountain View, California, focuses on designing, developing, and marketing implantable devices to treat neurological disorders through responsive stimulation. Their core mission is to improve the quality of life for patients with epilepsy by offering innovative, technology-driven solutions. The company's flagship product, the RNS System, provides personalized treatment by monitoring brain activity and delivering precise electrical stimulation to prevent seizures. NeuroPace targets both patients and healthcare providers, aiming to revolutionize epilepsy management.
Notable figures associated with NeuroPace include key investors from prominent venture capital firms and experts in neurology and medical device innovation. The company has achieved significant milestones, including FDA approval for the RNS System and widespread adoption in clinical settings. NeuroPace's impact is evident in the improved outcomes for epilepsy patients, reducing seizure frequency and enhancing overall patient well-being. Their pioneering work in responsive neurostimulation has positioned them as leaders in the field of neurological disorder treatment.
Companies similar to NeuroPace include Nevro, Cadence Neuroscience, Epic Neuro and Epalex.
NeuroPace was founded in 1997.
NeuroPace's headquarters is located in Mountain View, CA, US.
NeuroPace's most recent funding round was for $9.3M (USD) in June 2021.
As of Jun 30, 2021, NeuroPace has disclosed funding of $307.3M (USD). Undisclosed round amounts are excluded.
NeuroPace has 167 employees as of Feb 6, 2024.
